GB201119533D0 - Compounds for the treatment of neoplasia - Google Patents

Compounds for the treatment of neoplasia

Info

Publication number
GB201119533D0
GB201119533D0 GBGB1119533.6A GB201119533A GB201119533D0 GB 201119533 D0 GB201119533 D0 GB 201119533D0 GB 201119533 A GB201119533 A GB 201119533A GB 201119533 D0 GB201119533 D0 GB 201119533D0
Authority
GB
United Kingdom
Prior art keywords
neoplasia
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1119533.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Oxford Ltd
Original Assignee
Summit Oxford Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Oxford Ltd filed Critical Summit Oxford Ltd
Priority to GBGB1119533.6A priority Critical patent/GB201119533D0/en
Publication of GB201119533D0 publication Critical patent/GB201119533D0/en
Ceased legal-status Critical Current

Links

GBGB1119533.6A 2011-11-14 2011-11-14 Compounds for the treatment of neoplasia Ceased GB201119533D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1119533.6A GB201119533D0 (en) 2011-11-14 2011-11-14 Compounds for the treatment of neoplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1119533.6A GB201119533D0 (en) 2011-11-14 2011-11-14 Compounds for the treatment of neoplasia

Publications (1)

Publication Number Publication Date
GB201119533D0 true GB201119533D0 (en) 2011-12-21

Family

ID=45421667

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1119533.6A Ceased GB201119533D0 (en) 2011-11-14 2011-11-14 Compounds for the treatment of neoplasia

Country Status (1)

Country Link
GB (1) GB201119533D0 (en)

Similar Documents

Publication Publication Date Title
HRP20190491T1 (en) 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
HK1212627A1 (en) Thienotriazolodiazepine compounds for treating neoplasia
HK1197400A1 (en) Compounds for the treatment of hiv hiv
AP3544A (en) Compounds for the treatment of addiction
ZA201403795B (en) Formulations for the treatment of diabetes
EP2723384A4 (en) Treatment of proteinopathies
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
HK1185874A1 (en) Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer 4--n--
IL226677A (en) Compounds for the reduction of ß-amyloid production
EP2536436A4 (en) Antimir-451 for the treatment of polycythemias
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
GB201119690D0 (en) Process for the preparation of compounds
PL393916A1 (en) Process for the preparation of carbapenemic compounds
GB201119533D0 (en) Compounds for the treatment of neoplasia
GB201019110D0 (en) Compounds for the treatment of neoplasia
HK1196953A1 (en) Formulations for the treatment of diabetes
GB201106981D0 (en) Compounds for the treatment of clostridium difficle-associated disease
GB0920317D0 (en) Compounds for the treatment of neoplasia
GB0906202D0 (en) Compounds for the treatment of neoplasia
GB0908699D0 (en) Compounds for the treatment of neoplasia
GB0914476D0 (en) Compounds for the treatment of neoplasia
GB201215527D0 (en) Compounds for the treatment of muscular dystrophy
GB201105302D0 (en) Treatment of acidosis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)